Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07046936 · ClinicalTrials.gov registry record
Role of Mitochondrial Bioenergetics in Resilience for Gynecologic Cancer
A clinical trial of Gynecologycal Cancer, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- 30
- Enrollment target
- 2
- Study locations
NCT07046936 is a study of Gynecologycal Cancer that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 30 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT07046936, a study of Gynecologycal Cancer, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this research study is to see if patients with endometrial and ovarian cancer are willing to complete physical and cognitive assessments before treatment and again after treatment has ended.
Conditions Studied
Interventions
- OTHER blood draw
- DIAGNOSTIC_TEST muscle sample
Study Locations (2)
North Carolina
- Atrium Health Levine Cancer - Charlotte
- Atrium Health Wake Forest Baptist Comprehensive Cancer Center - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-06 |
| Est. Completion | 2027-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07046936
The ClinicalTrials.gov registry entry for NCT07046936 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gynecologycal Cancer appearing as the primary indexed condition, and to 2 interventions - of which blood draw is the first listed.
NCT07046936 reports 2 study locations spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT07046936 about?
NCT07046936 is a clinical study titled "Role of Mitochondrial Bioenergetics in Resilience for Gynecologic Cancer". The purpose of this research study is to see if patients with endometrial and ovarian cancer are willing to complete physical and cognitive assessments before treatment and again after treatment has ended.
What is the current status of trial NCT07046936?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2026-06. Estimated completion is 2027-04.
What conditions does trial NCT07046936 study?
This clinical trial studies the following conditions: Gynecologycal Cancer.
What interventions are being tested in trial NCT07046936?
The interventions under investigation include: blood draw (OTHER), muscle sample (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07046936?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07046936 being conducted?
This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.